BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 30249710)

  • 1. Refining the Application of Microbial Lipids as Tracers of Staphylococcus aureus Growth Rates in Cystic Fibrosis Sputum.
    Neubauer C; Kasi AS; Grahl N; Sessions AL; Kopf SH; Kato R; Hogan DA; Newman DK
    J Bacteriol; 2018 Dec; 200(24):. PubMed ID: 30249710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trace incorporation of heavy water reveals slow and heterogeneous pathogen growth rates in cystic fibrosis sputum.
    Kopf SH; Sessions AL; Cowley ES; Reyes C; Van Sambeek L; Hu Y; Orphan VJ; Kato R; Newman DK
    Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E110-6. PubMed ID: 26715741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards measuring growth rates of pathogens during infections by D
    Neubauer C; Sessions AL; Booth IR; Bowen BP; Kopf SH; Newman DK; Dalleska NF
    Rapid Commun Mass Spectrom; 2018 Dec; 32(24):2129-2140. PubMed ID: 30252972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.
    Fodor AA; Klem ER; Gilpin DF; Elborn JS; Boucher RC; Tunney MM; Wolfgang MC
    PLoS One; 2012; 7(9):e45001. PubMed ID: 23049765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis and bacterial colonization define the sputum N-glycosylation phenotype.
    Venkatakrishnan V; Thaysen-Andersen M; Chen SC; Nevalainen H; Packer NH
    Glycobiology; 2015 Jan; 25(1):88-100. PubMed ID: 25190359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous antibiotics given for 2 weeks do not eradicate persistent Staphylococcus aureus clones in cystic fibrosis patients.
    Andersen C; Kahl BC; Olesen HV; Jensen-Fangel S; Nørskov-Lauritsen N
    Clin Microbiol Infect; 2014 May; 20(5):O285-91. PubMed ID: 24112282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
    Phaff SJ; Tiddens HA; Verbrugh HA; Ott A
    J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients.
    Vergison A; Denis O; Deplano A; Casimir G; Claeys G; DeBaets F; DeBoeck K; Douat N; Franckx H; Gigi J; Ieven M; Knoop C; Lebeque P; Lebrun F; Malfroot A; Paucquay F; Pierard D; Van Eldere J; Struelens MJ
    J Antimicrob Chemother; 2007 May; 59(5):893-9. PubMed ID: 17341469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Same Game, Different Players: Emerging Pathogens of the CF Lung.
    Gannon AD; Darch SE
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis.
    Armbruster CR; Li K; Kiedrowski MR; Zemke AC; Melvin JA; Moore J; Atteih S; Fitch AC; DuPont M; Manko CD; Weaver ML; Gaston JR; Alcorn JF; Morris A; Methé BA; Lee SE; Bomberger JM
    Microbiol Spectr; 2022 Oct; 10(5):e0125122. PubMed ID: 36094193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained Coinfections with
    Fischer AJ; Singh SB; LaMarche MM; Maakestad LJ; Kienenberger ZE; Peña TA; Stoltz DA; Limoli DH
    Am J Respir Crit Care Med; 2021 Feb; 203(3):328-338. PubMed ID: 32750253
    [No Abstract]   [Full Text] [Related]  

  • 12. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial Culture Underestimates Lung Pathogen Detection and Infection Status in Cystic Fibrosis.
    Gavillet H; Hatfield L; Rivett D; Jones A; Maitra A; Horsley A; van der Gast C
    Microbiol Spectr; 2022 Oct; 10(5):e0041922. PubMed ID: 35972283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis.
    Liou TG; Adler FR; Argel N; Asfour F; Brown PS; Chatfield BA; Daines CL; Durham D; Francis JA; Glover B; Heynekamp T; Hoidal JR; Jensen JL; Keogh R; Kopecky CM; Lechtzin N; Li Y; Lysinger J; Molina O; Nakamura C; Packer KA; Poch KR; Quittner AL; Radford P; Redway AJ; Sagel SD; Sprandel S; Taylor-Cousar JL; Vroom JB; Yoshikawa R; Clancy JP; Elborn JS; Olivier KN; Cox DR
    BMC Med Res Methodol; 2019 Apr; 19(1):88. PubMed ID: 31027503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis.
    Wolter DJ; Emerson JC; McNamara S; Buccat AM; Qin X; Cochrane E; Houston LS; Rogers GB; Marsh P; Prehar K; Pope CE; Blackledge M; Déziel E; Bruce KD; Ramsey BW; Gibson RL; Burns JL; Hoffman LR
    Clin Infect Dis; 2013 Aug; 57(3):384-91. PubMed ID: 23625938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
    Zemanick ET; Harris JK; Wagner BD; Robertson CE; Sagel SD; Stevens MJ; Accurso FJ; Laguna TA
    PLoS One; 2013; 8(4):e62917. PubMed ID: 23646159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.
    de Dios Caballero J; Vida R; Cobo M; Máiz L; Suárez L; Galeano J; Baquero F; Cantón R; Del Campo R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28951476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum.
    Palmer KL; Aye LM; Whiteley M
    J Bacteriol; 2007 Nov; 189(22):8079-87. PubMed ID: 17873029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
    Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
    Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus.
    Junge S; Görlich D; den Reijer M; Wiedemann B; Tümmler B; Ellemunter H; Dübbers A; Küster P; Ballmann M; Koerner-Rettberg C; Große-Onnebrink J; Heuer E; Sextro W; Mainz JG; Hammermann J; Riethmüller J; Graepler-Mainka U; Staab D; Wollschläger B; Szczepanski R; Schuster A; Tegtmeyer FK; Sutharsan S; Wald A; Nofer JR; van Wamel W; Becker K; Peters G; Kahl BC
    PLoS One; 2016; 11(11):e0166220. PubMed ID: 27861524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.